Integra LifeSciences Holdings Corporation

IART · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$232,186$217,914$239,104$246,375
Short-Term Investments$35,693$35,694$34,191$27,192
Receivables$262,160$284,507$252,446$272,370
Inventory$489,106$465,127$445,418$429,090
Other Curr. Assets$124,437$139,586$136,088$106,654
Total Curr. Assets$1,143,582$1,142,828$1,107,247$1,081,681
Property Plant & Equip (Net)$575,554$571,388$561,376$549,765
Goodwill$615,199$616,427$1,105,386$1,096,952
Intangibles$1,160,145$1,188,080$1,187,535$1,207,588
Long-Term Investments$0$18,502$26,935$38,302
Tax Assets$109,728$102,943$38,008$34,923
Other NC Assets$42,244$27,737$26,264$28,213
Total NC Assets$2,502,870$2,525,077$2,945,504$2,955,743
Other Assets$0$0$0$0
Total Assets$3,646,452$3,667,905$4,052,751$4,037,424
Liabilities
Payables$92,305$92,835$91,296$82,502
Short-Term Debt$52,576$627,554$626,820$621,616
Tax Payable$0$0$0$0
Deferred Revenue$11,326$11,103$10,539$10,483
Other Curr. Liab.$207,847$198,314$189,797$207,525
Total Curr. Liab.$364,054$929,806$918,452$922,126
LT Debt$1,953,284$1,386,215$1,392,117$1,362,947
Deferred Rev, NC$0$0$9,400$9,200
Deferred Tax Liab, NC$58,285$60,064$57,581$60,833
Other NC Liab.$233,255$253,159$151,062$137,038
Total NC Liab.$2,244,824$1,699,438$1,610,160$1,570,018
Other Liabilities$0$0$0$0
Cap. Leases$174,759$173,449$175,647$181,470
Total Liabilities$2,608,878$2,629,244$2,528,612$2,492,144
Equity
Pref Stock$0$0$0$0
Common Stock$923$923$921$916
Retained Earnings$425,145$430,549$914,622$939,915
AOCI-$31,975-$30,907-$24,106-$27,571
Other Equity$643,481$638,096$632,702$632,020
Total Equity$1,037,574$1,038,661$1,524,139$1,545,280
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$3,646,452$3,667,905$4,052,751$4,037,424
Net Debt$1,773,674$1,795,855$1,779,833$1,738,188